Process Industries
Ube Industries Ltd.
- 2,010.00 JPY
- -20.00
- -0.99%
Japan
Aug 20, 2019Ticker
TKS(4208)Prev. close
2,030Market cap (JPY)
215,586.20MMarket cap (USD)
2,024.37MShares
106.20M
In the news
- Trade war opens commodity floodgates Feb 10, 2019
- Mazda to develop lithium-ion starter batteries Mar 15, 2018
- China's environmental crackdown means big business for Japan Feb 23, 2018
- Japan's suppliers eagerly eye market for foldable smartphones Feb 12, 2018
- Mitsubishi Chemical prepping for electric-vehicle age Nov 28, 2017 See more articles on Ube Industries Ltd.
Business Summary
Ube Industries Ltd. engages in the chemical, pharmaceutical, construction material, machinery and metal, and energy and environment businesses. It operates through the following business segments: Chemicals, Pharmaceuticals, Cement and Construction Materials, Machinery, Energy and Environment, and Others. The Chemicals segment offers caprolactam, industrial chemicals, synthetic rubbers, battery materials, fine chemicals, and polyimide. The Pharmaceuticals segment deals with the manufacture and sale of proprietary drugs, active pharmaceutical ingredients, and intermediates. The Cement and Construction Materials segment includes cement, ready-mix concrete, limestone, calcium magnesia, building materials, functional inorganic materials, and resource recycling. The Machinery segment manages the manufacture and sale of molding machinery, industrial machinery, bridge and iron structure, and steel products. The Energy and Environment segment handles the sale and import of coal, call center operation, and wholesale power supply business (IPP). The Others segment consists of the development, sale, and brokerage of real estate properties as well as the sale of products overseas. The company was founded by Sukesaku Watanabe in June 1897 and is headquartered in Ube, Japan.
Financial Highlights
| Mar 2019 | JPY | USD |
| Revenue | 730,157M | 6,584.23M |
| Gross Profit | 130,173M | 1,173.84M |
| Operating income | 44,551M | 401.74M |
| Income before tax | 44,678M | 402.88M |
| Net income | 32,499M | 293.06M |
| EBITDA | 81,118M | 731.48M |
| Diluted EPS | 311.35 | 2.80 |
| Dividends Per Share | 80 | 0.72 |
| Total Assets | 740,286M | 6,688.22M |
| Total liabilities | 385,734M | 3,484.97M |
| Total equity | 330,146M | 2,982.75M |
| Operating cash flow | 50,462M | 455.04M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 641,759M | 641,750M | 616,563M | 695,574M | 730,157M |
| Gross Profit | 102,720M | 121,709M | 115,901M | 135,664M | 130,173M |
| Operating income | 23,999M | 41,261M | 34,818M | 50,250M | 44,551M |
| Income before tax | 18,491M | 27,653M | 32,933M | 45,000M | 44,678M |
| Net income | 14,649M | 19,111M | 24,185M | 31,680M | 32,499M |
| EBITDA | 57,733M | 76,982M | 69,450M | 85,749M | 81,118M |
| Diluted EPS | 138.10 | 180.10 | 227.80 | 300.63 | 311.35 |
| Dividends Per Share | 50 | 50 | 60 | 75 | 80 |
| Total Assets | 711,546M | 679,783M | 709,379M | 742,445M | 740,286M |
| Total liabilities | 420,951M | 389,203M | 398,978M | 405,584M | 385,734M |
| Total equity | 263,892M | 267,159M | 287,222M | 316,024M | 330,146M |
| Operating cash flow | 62,194M | 68,628M | 53,418M | 73,386M | 50,462M |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 5,841.79M | 5,344.16M | 5,693.75M | 6,275.90M | 6,584.23M |
| Gross Profit | 935.03M | 1,013.52M | 1,070.30M | 1,224.04M | 1,173.84M |
| Operating income | 218.45M | 343.60M | 321.53M | 453.38M | 401.74M |
| Income before tax | 168.31M | 230.27M | 304.12M | 406.01M | 402.88M |
| Net income | 133.34M | 159.14M | 223.34M | 285.83M | 293.06M |
| EBITDA | 525.53M | 641.06M | 641.34M | 773.68M | 731.48M |
| Diluted EPS | 1.25 | 1.49 | 2.10 | 2.71 | 2.80 |
| Dividends Per Share | 0.45 | 0.41 | 0.55 | 0.67 | 0.72 |
| Total Assets | 5,933.25M | 6,048.16M | 6,366.14M | 6,981.14M | 6,688.22M |
| Total liabilities | 3,510.11M | 3,462.81M | 3,580.52M | 3,813.67M | 3,484.97M |
| Total equity | 2,200.47M | 2,376.96M | 2,577.60M | 2,971.54M | 2,982.75M |
| Operating cash flow | 566.13M | 571.49M | 493.29M | 662.13M | 455.04M |
Valuation Measures
| Mar 2019 | |
| PER | 7.28 |
| ROA | 4.38% |
| ROE | 10.05% |
| Operating margin | 6.10% |
| Profit margin | 4.45% |
Key executives
- President & Representative Director: Masato Izumihara
- Group CFO & Manager-Business Administration: Masayuki Fujii
- Executive Officer, GM-Research & Development: Morihisa Yokota
- Chief Compliance Officer & Manager-Personnel: Hideo Tamada
- Executive Officer: Makoto Aikawa
Shareholders
- Ube Industries Ltd. (4.8%)
- Asset Management One Co., Ltd. (3.7%)
- BlackRock Fund Advisors (3.3%)
- Nomura Asset Management Co., Ltd. (2.9%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.9%)
- BlackRock Investment Management LLC (2.9%)
- The Vanguard Group, Inc. (2.4%)
- Nikko Asset Management Co., Ltd. (1.9%)
- Sumitomo Life Insurance Co. (1.8%)
- Dimensional Fund Advisors LP (1.8%)
Contact Details
- Website:http://www.ube-ind.co.jp
- Phone: +81.836.31.2111
Related Companies
- UBE Exsymo Co., Ltd.
- Lotte Ube Synthetic Rubber Sdn. Bhd.
- Ube Industries Central Hospital Corp.
- UBE Industries India Pvt Ltd.
- UBE (Thailand) Co. Ltd.
- UBE-Nitto Kasei (Wuxi) Co. Ltd.
- UBE Machinery Thai Co. Ltd.
- UBE Korea Co. Ltd.
- Advanced Electrolyte Technologies LLC
- Ube Industries Pension Fund
- Ubon Bio Ethanol PCL
- Ube Asset & Insurance Ltd.
- Ana Hotel Ube Ltd.
- Ube Realty & Development Co. Ltd.
- Libertas Ube Ltd.
- UBE (Shanghai) Ltd.
- UBE (Hong Kong) Ltd.
- UBE Singapore Pte Ltd.
- Ube Industries Consulting Ltd.
- Yamayo Trading Co. Ltd.
- Ube Aluminum Wheels Ltd.
- Fukusei Tech Co. Ltd.
- Fukusei Vender Service Co. Ltd.
- Nantong Ube Concrete Co. Ltd.
- Kitakyushu Ube Concrete Co. Ltd.
- Kano Ube Concrete Co. Ltd.
- Nishiharima Ube Co. Ltd.
- Kansai Ube Co. Ltd.
- Chiba Ube Concrete Co. Ltd.
- Ozawa Corp.
Competitors
- BASF SE
- Arkema SA
- AdvanSix, Inc.
- Shenzhen Capchem Technology Co., Ltd. Class A
- Guangdong Yizumi Precision Machinery Co. Ltd. Class A
- Kaset Thai International Sugar Corp. Public Co. Ltd.
- CytoSorbents Corporation
- Syros Pharmaceuticals, Inc.
Copyright © 2019 FactSet Research Systems Inc. All rights reserved.
Last Updated on 20 Aug, 2019